You need JavaScript to view this

FY 2000 report on the results of the regional consortium R and D project - Regional new technology creation R and D. First year report. R and D of medicine toxicity assessment use hepatocyte chip; 2000 nendo chiiki consortium kenkyu kaihatsu jigyo. Chiiki consortium kenkyu kaihatsu / chiiki shingijutsu soshutsu kenkyu kaihatsu. Dokubutsu dokusei hyokayo kansaibo chip no kenkyu kaihatsu (dai 1 nendo) seika hokokusho

Abstract

Judging that in the beginning of the toxicity test, the necessary information/knowledge are acquired not by using animal itself but only by using liver system (hepatocyte), the development was proceeded with of the hepatocyte chip substituting for the animal experiment. Studies were made in the following five fields: 1) design of functional matrices; 2) development of the pharmacological assessment technology; 3) development of cell sensing technology/biosensor fabrication; 4) study of a possibility and the limit of cell patterning technology; 5) survey of the market scale. In 1), studies were made of the establishment of the 3D culture method for hepatocyte and the construction of hepatocyte models for medicine assessment using pieces of liver. In the latter, by including capsule using the sugar introduced with galactose residue which is special sugar of hepatocyte to alginic acid and chitosan which are natural polymer and also hepatocyte isolated into sponge, aggregate was formed, and its use as a medicine assessment use liver model was tried to be made. (NEDO)
Authors:
"NONE"
Publication Date:
Mar 01, 2001
Product Type:
Technical Report
Report Number:
JP-NEDO-010017430
Resource Relation:
Other Information: PBD: Mar 2001
Subject:
99 GENERAL AND MISCELLANEOUS//MATHEMATICS, COMPUTING, AND INFORMATION SCIENCE; TOXICITY; BIOASSAY; PHARMACOLOGY; METABOLISM; LIVER CELLS; LIVER; CELL CULTURES; CULTURE MEDIA; ALGINIC ACID; GALACTOSE; CAPSULES; POLYMERS
OSTI ID:
20203000
Research Organizations:
New Energy and Industrial Technology Development Organization, Tokyo (Japan)
Country of Origin:
Japan
Language:
Japanese
Other Identifying Numbers:
TRN: JN0140728
Availability:
Available to ETDE participating countries only(see www.etde.org); commercial reproduction prohibited; OSTI as DE20203000
Submitting Site:
NEDO
Size:
88 pages
Announcement Date:

Citation Formats

FY 2000 report on the results of the regional consortium R and D project - Regional new technology creation R and D. First year report. R and D of medicine toxicity assessment use hepatocyte chip; 2000 nendo chiiki consortium kenkyu kaihatsu jigyo. Chiiki consortium kenkyu kaihatsu / chiiki shingijutsu soshutsu kenkyu kaihatsu. Dokubutsu dokusei hyokayo kansaibo chip no kenkyu kaihatsu (dai 1 nendo) seika hokokusho. Japan: N. p., 2001. Web.
FY 2000 report on the results of the regional consortium R and D project - Regional new technology creation R and D. First year report. R and D of medicine toxicity assessment use hepatocyte chip; 2000 nendo chiiki consortium kenkyu kaihatsu jigyo. Chiiki consortium kenkyu kaihatsu / chiiki shingijutsu soshutsu kenkyu kaihatsu. Dokubutsu dokusei hyokayo kansaibo chip no kenkyu kaihatsu (dai 1 nendo) seika hokokusho. Japan.
2001. "FY 2000 report on the results of the regional consortium R and D project - Regional new technology creation R and D. First year report. R and D of medicine toxicity assessment use hepatocyte chip; 2000 nendo chiiki consortium kenkyu kaihatsu jigyo. Chiiki consortium kenkyu kaihatsu / chiiki shingijutsu soshutsu kenkyu kaihatsu. Dokubutsu dokusei hyokayo kansaibo chip no kenkyu kaihatsu (dai 1 nendo) seika hokokusho." Japan.
@misc{etde_20203000,
title = {FY 2000 report on the results of the regional consortium R and D project - Regional new technology creation R and D. First year report. R and D of medicine toxicity assessment use hepatocyte chip; 2000 nendo chiiki consortium kenkyu kaihatsu jigyo. Chiiki consortium kenkyu kaihatsu / chiiki shingijutsu soshutsu kenkyu kaihatsu. Dokubutsu dokusei hyokayo kansaibo chip no kenkyu kaihatsu (dai 1 nendo) seika hokokusho}
abstractNote = {Judging that in the beginning of the toxicity test, the necessary information/knowledge are acquired not by using animal itself but only by using liver system (hepatocyte), the development was proceeded with of the hepatocyte chip substituting for the animal experiment. Studies were made in the following five fields: 1) design of functional matrices; 2) development of the pharmacological assessment technology; 3) development of cell sensing technology/biosensor fabrication; 4) study of a possibility and the limit of cell patterning technology; 5) survey of the market scale. In 1), studies were made of the establishment of the 3D culture method for hepatocyte and the construction of hepatocyte models for medicine assessment using pieces of liver. In the latter, by including capsule using the sugar introduced with galactose residue which is special sugar of hepatocyte to alginic acid and chitosan which are natural polymer and also hepatocyte isolated into sponge, aggregate was formed, and its use as a medicine assessment use liver model was tried to be made. (NEDO)}
place = {Japan}
year = {2001}
month = {Mar}
}